The Fuss with Phylos

468

The company started as a testing lab and a cannabis database. When they announced they’d start doing plant breeding, the industry erupted with anger. Josh Jardine sits down with Phylos’ CEO to hear his side

Since April, the cannabis world has been reeling in response to news from Phylos Bioscience, about whose innovative “Galaxy” I have written in the past. The Galaxy is aimed at being “the world’s largest database of hemp and cannabis genetic insights featuring thousands of heritage and modern varieties from over 80 countries,” according to Phylos’ website.

The announcement that launched thousands of enraged Instagram comments, severed partnerships, and calls for boycotts? The one stating that Phylos is entering the cannabis-breeding business. That news might seem innocuous to those outside the industry, but for those inside, many considered it to be a

Ga naar Bron